concept

LYSOSOMAL DYSFUNCTION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about LYSOSOMAL DYSFUNCTION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

170Connections

2Hypotheses

13Analyses

50Outgoing

50Incoming

0Experiments

13Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	LYSOSOMAL DYSFUNCTION
Key Genes/Proteins	ABCA1, ALPHA-SYNUCLEIN, AMYLOID, APOE, C9orf72, CTSB
Related Diseases	ALS, CERAMIDE, CHOLESTEROL, DEMENTIA, DOPAMINE

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Lysosomal Dysfunction in Neurodegeneration

mechanism · 3582 words

→

Pathway Diagram

graph TD
    LYSOSOMAL_DYSFUNCTION["LYSOSOMAL DYSFUNCTION"]
    LYSOSOMAL_DYSFUNCTION -->|"causes"| Neurodegenerative_Diseases["Neurodegenerative Diseases"]
    LYSOSOMAL_DYSFUNCTION -->|"contributes to"| LIPID_ACCUMULATION["LIPID ACCUMULATION"]
    LYSOSOMAL_DYSFUNCTION -->|"contributes to"| Parkinson_Disease["Parkinson Disease"]
    LYSOSOMAL_DYSFUNCTION -->|"contributes to"| Insulin_Resistance["Insulin Resistance"]
    LYSOSOMAL_DYSFUNCTION -->|"contributes to"| Lipid_Accumulation["Lipid Accumulation"]
    LYSOSOMAL_DYSFUNCTION -->|"causes"| Lysosomal_Storage_Diseases["Lysosomal Storage Diseases"]
    LYSOSOMAL_DYSFUNCTION -->|"contributes to"| Parkinson_s_Disease["Parkinson's Disease"]
    LYSOSOMAL_DYSFUNCTION -->|"contributes to"| Neurodegeneration["Neurodegeneration"]
    VCP["VCP"] -->|"causes"| LYSOSOMAL_DYSFUNCTION
    Obesity["Obesity"] -->|"causes"| LYSOSOMAL_DYSFUNCTION
    TREM2_p_Q33X_mutation["TREM2 p.Q33X mutation"] -->|"causes"| LYSOSOMAL_DYSFUNCTION
    GBA["GBA"] -->|"regulates"| LYSOSOMAL_DYSFUNCTION
    Cellular_Ageing["Cellular Ageing"] -->|"contributes to"| LYSOSOMAL_DYSFUNCTION
    Autophagy["Autophagy"] -->|"regulates"| LYSOSOMAL_DYSFUNCTION
    TBK1["TBK1"] -.prevents.-> LYSOSOMAL_DYSFUNCTION
    Glycerophosphodiesters["Glycerophosphodiesters"] -->|"correlates_with"| LYSOSOMAL_DYSFUNCTION

Outgoing (64)

Target	Relation	Type	Str
Defective Mitophagy	causes	phenotype	0.92
Microglial clearance capacity	associated_with	phenotype	0.90
synucleinopathies	associated_with	disease	0.90
LIPID ACCUMULATION	contributes_to	entity	0.90
Neurodegenerative Diseases	associated_with	disease	0.90
Parkinson Disease	contributes_to	disease	0.90
Autophagosome-lysosome Fusion	inhibits	phenotype	0.90
alpha-synuclein aggregation	causes	phenotype	0.90
Insulin Resistance	contributes_to	phenotype	0.90
Proximal Tubular Epithelial Cells	contributes_to	cell_type	0.90
Neurodegenerative Diseases	causes	disease	0.90
Cellular Senescence	promotes	phenotype	0.85
Parkinson's Disease	contributes_to	disease	0.85
Lysosomal Storage Diseases	causes	disease	0.85
Neuroinflammation	promotes	process	0.85
Mitochondrial Dysfunction	contributes_to	phenotype	0.85
mitochondrial apoptosis	associated_with	process	0.85
lipid accumulation	promotes	process	0.85
Foam Cell Phenotype	contributes_to	phenotype	0.85
Disease Development	contributes_to	process	0.85
Lipid Accumulation	associated_with	process	0.85
Mitochondria-Lysosome Contacts	associated_with	mechanism	0.80
Proteotoxic Stress	contributes_to	process	0.80
Lysosomal Storage Diseases	contributes_to	disease	0.80
tau pathology clearance	associated_with	process	0.80
α-synuclein aggregation	causes	pathology	0.80
Lipotoxicity	contributes_to	phenotype	0.80
Neurodegeneration	contributes_to	disease	0.80
TFEB activation	causes (dysfunction precedes and triggers compensatory TFE)	mechanism	0.75
NDDs	associated_with	disease	0.70
TFEB activation	causes	phenotype	0.70
PROTEIN_AGGREGATION	causes	phenotype	0.70
carcinoma	associated_with	disease	0.70
Alzheimer's disease	associated_with	disease	0.70
Alzheimer's disease	causes	disease	0.70
ALS	associated_with	disease	0.70
FTD	associated_with	disease	0.70
frontotemporal dementia	causes	disease	0.70
amyotrophic lateral sclerosis	causes	disease	0.70
ALS	causes	disease	0.70
PHAGOCYTOSIS	inhibits	phenotype	0.65
PERICYTE	causes	cell_type	0.65
TFEB	regulates	gene	0.65
INFLAMMATION	exacerbates	phenotype	0.65
INFLAMMATION	causes	phenotype	0.65
STEM CELLS	treats	cell_type	0.65
INSULIN RESISTANCE	inhibits	phenotype	0.65
INSULIN RESISTANCE	exacerbates	phenotype	0.65
INSULIN RESISTANCE	causes	phenotype	0.65
Mitochondrial dysfunction	causes	cellular_mechanism	0.65

Incoming (106)

Source	Relation	Type	Str
SLC45A1	regulates	protein	0.95
VCP	causes	gene	0.95
Obesity	causes	disease	0.95
CTSD Deficiency	causes	phenotype	0.95
VCP mutant microglia	exhibits	cell_type	0.90
GBA	regulates	entity	0.90
TREM2 p.Q33X mutation	causes	gene	0.90
27209302	leads to	paper	0.90
bafilomycin	causes	drug	0.90
GBA-PD	causes	phenotype	0.90
GBA mutations	causes	gene	0.90
Schaftoside	associated_with	compound	0.88
LAMP2	associated_with	protein	0.85
LRRK2	causes	protein	0.85
Cellular Ageing	contributes_to	process	0.85
Amyloid Beta	associated_with	protein	0.85
Glycerophosphodiesters	correlates_with	compound	0.85
TBK1	prevents	gene	0.85
Autophagy	regulates	process	0.85
GBA1 loss-of-function	causes	genetic_risk	0.85
GBA1	causes	gene	0.80
AMYOTROPHIC LATERAL SCLEROSIS	associated_with	gene	0.80
OXIDATIVE STRESS	causes	process	0.80
lysophagy	protects_against	process	0.80
mitochondrial dysfunction	interacts_with	phenotype	0.75
Polyamines	modulates	compound	0.75
TFEB	modulates	gene	0.75
NEURONS	causes	cell_type	0.70
amyloid-beta	causes	protein	0.70
AMYLOID	protects_against	protein	0.70
C9orf72	causes	gene	0.70
apoe4	causes	disease	0.70
TDP-43	activates	protein	0.70
GRN	causes	gene	0.70
MAPT	causes	gene	0.70
APOE4	causes	gene	0.70
LAMP1 upregulation	associated_with	phenotype	0.70
microglia	associated_with	cell_type	0.70
neurons	inhibits	cell_type	0.70
LAMP1	associated_with	gene	0.70
autophagy pathway	mediates	pathway	0.70
CTSD	associated_with	gene	0.70
PSEN1	causes	gene	0.70
TMEM175 variants	causes	gene	0.70
Bafilomycin	mimics	drug	0.70
LRRK2	causes	gene	0.70
TBK1	inhibits	gene	0.65
CHOLESTEROL	regulates	phenotype	0.65
CHOLESTEROL	causes	phenotype	0.65
GBA	encodes	gene	0.65

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Glucosylceramide Accumulation from GCase Deficiency Disrupts	0.700	neurodegeneration	-
APOE4 preferentially signals through LRP1 over LDLR, alterin	0.610	neuroscience	APOE4-driven lipid metabolism dysregulat

Mentioning Analyses (13)

Scientific analyses that reference this entity

Cross-disease neurodegeneration mechanism synthesis

neurodegeneration | 2026-04-28 | 17 hypotheses Top: 0.828

LRRK2 Risk Variants: Lysosomal Membrane Dynamics in DA vs Striatal Neurons

neurodegeneration | 2026-04-27 | 0 hypotheses

Microglial senescence in Alzheimer and Parkinson disease progression

neurodegeneration | 2026-04-26 | 0 hypotheses

Does APOE4 drive tau propagation

neurodegeneration | 2026-04-15 | 0 hypotheses

How does PSEN2 mechanistically regulate α-synuclein expression and pathology in

neurodegeneration | 2026-04-13 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (13)

Multi-agent debates referencing this entity

Which AD, PD, ALS, and FTD mechanisms recur across disease boundaries and yield

active · Rounds: 4 · Score: 0.72 · 2026-04-28

How do GWAS-identified PD risk variants at the LRRK2 locus alter lysosomal membr

active · Rounds: 6 · Score: 0.89 · 2026-04-27

Microglial senescence in Alzheimer and Parkinson disease progression

closed · Rounds: 6 · Score: 0.50 · 2026-04-25

Lysosomal membrane permeabilization releasing cathepsins triggers NLRP3 inflamma

closed · Rounds: 4 · Score: 0.76 · 2026-04-22

The abstract identifies APOE4 association with increased TDP-43 pathology but th

closed · Rounds: 4 · Score: 0.61 · 2026-04-21

The review covers various organelle-specific autophagy types but doesn't address

closed · Rounds: 4 · Score: 0.66 · 2026-04-21

The study shows PSEN2 is essential in cortical and dopaminergic neurons and regu

closed · Rounds: 4 · Score: 0.68 · 2026-04-16

Does APOE4 drive tau propagation [TARGET_ARTIFACT type=hypothesis id=TEST-123]

closed · Rounds: 4 · Score: 0.64 · 2026-04-16

Why have numerous phase 3 clinical trials failed despite advances in understandi

closed · Rounds: 5 · Score: 0.67 · 2026-04-12

Multiple NDDs converge on autophagy-lysosome dysfunction. Are there universal th

closed · Rounds: 4 · Score: 0.90 · 2026-04-06

Related Research

Hypotheses and analyses mentioning LYSOSOMAL DYSFUNCTION in their description or question text

No additional research found

LYSOSOMAL DYSFUNCTION

Understanding Entity Pages

Wiki Pages (1)

Lysosomal Dysfunction in Neurodegeneration

Pathway Diagram

Outgoing (64)

Incoming (106)

Targeting Hypotheses (2)

Mentioning Analyses (13)

Cross-disease neurodegeneration mechanism synthesis

LRRK2 Risk Variants: Lysosomal Membrane Dynamics in DA vs Striatal Neurons

Microglial senescence in Alzheimer and Parkinson disease progression

Does APOE4 drive tau propagation

How does PSEN2 mechanistically regulate α-synuclein expression and pathology in

Why have numerous phase 3 clinical trials failed despite advances in understandi

What determines organelle-specific autophagy selectivity in neurodegenerative di

How does APOE4 mechanistically increase TDP-43 pathology frequency in Alzheimer'

Lysosomal dysfunction and cathepsin leakage in Alzheimer disease progression

Does TFEB dysfunction cause neurodegeneration or represent a compensatory respon

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

GBA-Synuclein Loop Therapeutics for PD

Autophagy-lysosome pathway convergence across neurodegenerative diseases

Experiments (0)

Related Papers (0)

Debates (13)

Which AD, PD, ALS, and FTD mechanisms recur across disease boundaries and yield

How do GWAS-identified PD risk variants at the LRRK2 locus alter lysosomal membr

Microglial senescence in Alzheimer and Parkinson disease progression

Lysosomal membrane permeabilization releasing cathepsins triggers NLRP3 inflamma

The abstract identifies APOE4 association with increased TDP-43 pathology but th

The review covers various organelle-specific autophagy types but doesn't address

The study shows PSEN2 is essential in cortical and dopaminergic neurons and regu

Does APOE4 drive tau propagation [TARGET_ARTIFACT type=hypothesis id=TEST-123]

Why have numerous phase 3 clinical trials failed despite advances in understandi

Multiple NDDs converge on autophagy-lysosome dysfunction. Are there universal th

Related Research